A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
General Montana
Archived
•
July 12, 2026
•
3 views
HDT Bio Canada Inc. partners with McGill University and The Neuro to advance HDT-401, an investigational locally administered RNA immune activator, into Phase 1 clinical evaluation for glioblastoma in Canada
Source: https://missoulian.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original
"Network Cable Repairs from $29"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Retirement Health Care"
"Water and Showers while camping is so simple."